Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice.
Am J Gastroenterol
; 115(10): 1716-1718, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: covidwho-732652
ABSTRACT
INTRODUCTION:
We investigated the potential hepatotoxicity of lopinavir/ritonavir recently used in the treatment of Severe Acute Respiratory Syndrome Coronavirus.METHODS:
This is a retrospective cohort of critical patients in a teaching hospital 12 treated with lopinavir/ritonavir and 30 in the standard-of-care group.RESULTS:
Elevation occurred more frequently in patients treated with lopinavir/ritonavir (33% vs 6.7%).DISCUSSION:
Caution is advised regarding the use of lopinavir/ritonavir in the most severe cases of Severe Acute Respiratory Syndrome Coronavirus.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Antivirales
/
Neumonía Viral
/
Infecciones por Coronavirus
/
Ritonavir
/
Lopinavir
/
Ictericia
Tipo de estudio:
Estudio de cohorte
/
Estudios diagnósticos
/
Estudio observacional
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Anciano
/
Femenino
/
Humanos
/
Masculino
/
Middle aged
Idioma:
Inglés
Revista:
Am J Gastroenterol
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Ajg.0000000000000828
Similares
MEDLINE
...
LILACS
LIS